<?xml version="1.0"?>
<Articles JournalTitle="Case Reports in Clinical Practice">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Case Reports in Clinical Practice</JournalTitle>
      <Issn>2538-2683</Issn>
      <Volume>7</Volume>
      <Issue>5</Issue>
      <PubDate PubStatus="epublish">
        <Year>2023</Year>
        <Month>02</Month>
        <Day>12</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Non-Neoformans Pulmonary Cryptococcosis Due to Cryptococcus Laurentii in a Positive SARS-COV-2 Patient</title>
    <FirstPage>221</FirstPage>
    <LastPage>226</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Priscilla</FirstName>
        <LastName>Duran Luciano</LastName>
        <affiliation locale="en_US">Department of Medicine, Albert Einstein College of Medicine, New York, USA.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>11</Month>
        <Day>04</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2022</Year>
        <Month>01</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Non-neoformans Cryptococcus species were formerly considered to be saprophytes and nonpathogenic to humans [1-2]. However, the incidence of Cryptococcus laurentii infections in immunocompromised and immunocompetent patients has been gradually increasing over the last decades [1-2]. During the COVID-19 pandemic, multiple cases of opportunistic bacterial and fungal infections have been reported in patients after a severe SARS-CoV-2 infection. The author reports the first case of opportunistic pulmonary cryptococcosis caused by Cryptococcus laurentii in a severely ill COVID-19 patient who received treatment with Tocilizumab and dexamethasone. This case contributes to the expanding knowledge of emergent secondary infectious complications including opportunistic pathogens after a SARS-COV-2 infection.</abstract>
    <web_url>https://crcp.tums.ac.ir/index.php/crcp/article/view/617</web_url>
  </Article>
</Articles>
